McMinn Rachel 4
4 · Neurogene Inc. · Filed Mar 14, 2024
Insider Transaction Report
Form 4
Neurogene Inc.NGNE
McMinn Rachel
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (Right to buy)
2024-03-13+93,282→ 93,282 totalExercise: $36.06Exp: 2034-03-13→ Common Stock (93,282 underlying)
Footnotes (1)
- [F1]The option vests as to 1/4 of the total number of shares on March 13, 2025, and then 1/48 of the total number of shares will vest monthly thereafter, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.